An acquisition of second-tier brands like Efferdent and Luden's can only be good news for...
This kind of news is more notable for what it doesn’t mean than what it...
The ultimate impact in allowing local municipalities to regulate what’s prescription and what isn’t, will...
Divesting itself of its West Coast store base certainly would place Rite Aid in a...
If you judge CVS Caremark too harshly based solely on the handful of PBM contracts...
Economic recessions cause hardship to a lot of people, but it’s also during downturns that...
Improved sight lines, updated and provocative signage, space for a retail clinic operation — all...
This is the second new pharmacy technician certification program to be announced in a week...
The alliance between CVS Caremark's MinuteClinic and Allina Hospitals & Clinics may not be the...
If any retail observer still doubted the determination of Walgreens’ top managers to shake the...
Uninsured Floridians may find a new kind of stocking stuffer in their Christmas stockings this...
The fact that today’s consumers are not willing to give up their dietary nutrition as...
As the healthcare reform debate continues and discussions of public vs. private are tossed about,...
For two decades or more, independent pharmacy owners have been slammed by managed care, steady...
What’s really intriguing behind the return of a consumer division to Pfizer is the fact...
There is a big danger here, and it’s a danger that has less to do...
Nonadherence to prescription medications is a big problem — a $200 billion-a-year problem for the...
There still is widespread concern over the safety and efficacy of the new H1N1 influenza...
It’s like “Whack-a-Mole,” that game-arcade exercise in quick reflexes and frustration....
After months of hard-edged wrangling in Congress, on the Sunday morning political gab fests, on...
The adoption of electronic health records, electronic prescribing and other health information technology isn’t just...
No matter how this season breaks out — in terms of numbers of people who...
The two takeaways from this story are “the [U.S.] market is expected to grow at...
The real issue here is (and always has been) the inclusion of diabetes supplies as...
The most significant piece of news to come out of this (outside of the fact...